These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37987885)

  • 1. Role of the kisspeptin-KISS1R axis in the pathogenesis of chronic kidney disease and uremic cardiomyopathy.
    Dinh H; Kovács ZZA; Kis M; Kupecz K; Sejben A; Szűcs G; Márványkövi F; Siska A; Freiwan M; Pósa SP; Galla Z; Ibos KE; Bodnár É; Lauber GY; Goncalves AIA; Acar E; Kriston A; Kovács F; Horváth P; Bozsó Z; Tóth G; Földesi I; Monostori P; Cserni G; Podesser BK; Lehoczki A; Pokreisz P; Kiss A; Dux L; Csabafi K; Sárközy M
    Geroscience; 2024 Apr; 46(2):2463-2488. PubMed ID: 37987885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kisspeptin-1 receptor antagonist peptide-234 aggravates uremic cardiomyopathy in a rat model.
    Dinh H; Kovács ZZA; Márványkövi F; Kis M; Kupecz K; Szűcs G; Freiwan M; Lauber GY; Acar E; Siska A; Ibos KE; Bodnár É; Kriston A; Kovács F; Horváth P; Földesi I; Cserni G; Podesser BK; Pokreisz P; Kiss A; Dux L; Csabafi K; Sárközy M
    Sci Rep; 2023 Aug; 13(1):14046. PubMed ID: 37640761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.
    Kovács ZZA; Szűcs G; Freiwan M; Kovács MG; Márványkövi FM; Dinh H; Siska A; Farkas K; Kovács F; Kriston A; Horváth P; Kővári B; Cserni BG; Cserni G; Földesi I; Csont T; Sárközy M
    Sci Rep; 2021 Sep; 11(1):17495. PubMed ID: 34471171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic preconditioning protects the heart against ischemia-reperfusion injury in chronic kidney disease in both males and females.
    Sárközy M; Márványkövi FM; Szűcs G; Kovács ZZA; Szabó MR; Gáspár R; Siska A; Kővári B; Cserni G; Földesi I; Csont T
    Biol Sex Differ; 2021 Sep; 12(1):49. PubMed ID: 34488888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease.
    Wollenhaupt J; Frisch J; Harlacher E; Wong DWL; Jin H; Schulte C; Vondenhoff S; Moellmann J; Klinkhammer BM; Zhang L; Baleanu-Curaj A; Liehn EA; Speer T; Kazakov A; Werner C; van der Vorst EPC; Selejan SR; Hohl M; Böhm M; Kramann R; Biessen EAL; Lehrke M; Marx N; Jankowski J; Maack C; Boor P; Prates Roma L; Noels H
    Redox Biol; 2022 Oct; 56():102459. PubMed ID: 36099852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CB1 cannabinoid receptor antagonist attenuates left ventricular hypertrophy and Akt-mediated cardiac fibrosis in experimental uremia.
    Lin CY; Hsu YJ; Hsu SC; Chen Y; Lee HS; Lin SH; Huang SM; Tsai CS; Shih CC
    J Mol Cell Cardiol; 2015 Aug; 85():249-61. PubMed ID: 26093151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of urea transporter ameliorates uremic cardiomyopathy in chronic kidney disease.
    Kuma A; Wang XH; Klein JD; Tan L; Naqvi N; Rianto F; Huang Y; Yu M; Sands JM
    FASEB J; 2020 Jun; 34(6):8296-8309. PubMed ID: 32367640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.
    Di Marco GS; Reuter S; Kentrup D; Grabner A; Amaral AP; Fobker M; Stypmann J; Pavenstädt H; Wolf M; Faul C; Brand M
    Nephrol Dial Transplant; 2014 Nov; 29(11):2028-35. PubMed ID: 24875663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance.
    Edwards NC; Moody WE; Chue CD; Ferro CJ; Townend JN; Steeds RP
    JACC Cardiovasc Imaging; 2014 Jul; 7(7):703-14. PubMed ID: 25034920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212.
    Sárközy M; Gáspár R; Zvara Á; Siska A; Kővári B; Szűcs G; Márványkövi F; Kovács MG; Diószegi P; Bodai L; Zsindely N; Pipicz M; Gömöri K; Kiss K; Bencsik P; Cserni G; Puskás LG; Földesi I; Thum T; Bátkai S; Csont T
    Sci Rep; 2019 Feb; 9(1):1302. PubMed ID: 30718600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease.
    Lima Posada I; Soulié M; Stephan Y; Palacios Ramirez R; Bonnard B; Nicol L; Pitt B; Kolkhof P; Mulder P; Jaisser F
    J Am Heart Assoc; 2024 Jun; 13(12):e032971. PubMed ID: 38842271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of murine models of uremic cardiomyopathy.
    Soppert J; Frisch J; Wirth J; Hemmers C; Boor P; Kramann R; Vondenhoff S; Moellmann J; Lehrke M; Hohl M; van der Vorst EPC; Werner C; Speer T; Maack C; Marx N; Jankowski J; Roma LP; Noels H
    Kidney Int; 2022 Feb; 101(2):256-273. PubMed ID: 34774555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10.
    Curtis AE; Cooke JH; Baxter JE; Parkinson JR; Bataveljic A; Ghatei MA; Bloom SR; Murphy KG
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E296-303. PubMed ID: 19934405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of augmented kisspeptin signaling through H
    Banerjee AA; Bhanarkar SR; Keshwani R; Pande S; Modi DN; Mehta A; Bombe S; Pathak BR; Joshi B; Tandon D; Patil A; Begum S; Chauhan S; Mahale SD; Rao S; Surve SV
    Gene; 2024 Feb; 895():148016. PubMed ID: 37981083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative proteomic analysis of rat left ventricle in a subtotal nephrectomy model.
    Lin YP; Yu WC; Hsu ME; Tsai HC; Liao CC; Lin CH
    J Chin Med Assoc; 2015 Apr; 78(4):218-28. PubMed ID: 25537970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH Neuron-Specific Ablation of Gαq/11 Results in Only Partial Inactivation of the Neuroendocrine-Reproductive Axis in Both Male and Female Mice: In Vivo Evidence for Kiss1r-Coupled Gαq/11-Independent GnRH Secretion.
    Babwah AV; Navarro VM; Ahow M; Pampillo M; Nash C; Fayazi M; Calder M; Elbert A; Urbanski HF; Wettschureck N; Offermanns S; Carroll RS; Bhattacharya M; Tobet SA; Kaiser UB
    J Neurosci; 2015 Sep; 35(37):12903-16. PubMed ID: 26377475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining Myocardial Abnormalities Across the Stages of Chronic Kidney Disease: A Cardiac Magnetic Resonance Imaging Study.
    Hayer MK; Radhakrishnan A; Price AM; Liu B; Baig S; Weston CJ; Biasiolli L; Ferro CJ; Townend JN; Steeds RP; Edwards NC;
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2357-2367. PubMed ID: 32682713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kisspeptin Stimulation of Prolactin Secretion Requires Kiss1 Receptor but Not in Tuberoinfundibular Dopaminergic Neurons.
    Aquino NSS; Kokay IC; Perez CT; Ladyman SR; Henriques PC; Silva JF; Broberger C; Grattan DR; Szawka RE
    Endocrinology; 2019 Mar; 160(3):522-533. PubMed ID: 30668693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations.
    Law JP; Pickup L; Pavlovic D; Townend JN; Ferro CJ
    J Hum Hypertens; 2023 Jan; 37(1):1-19. PubMed ID: 36138105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.